Science Stories
Extensive-stage small cell lung cancer remains one of the most aggressive and difficult-to-treat cancers, with most patients relapsing within months of initial therapy. Maintenance therapy may turn the period of stability after their first treatment into an opportunity to extend response and delay relapse.
Discover how advancing HER2 science is reshaping cancer care. By deepening understanding of tumor complexity and leveraging biomarker-driven approaches, we are enabling more precise therapies and driving innovation to improve outcomes for patients with HER2-expressing cancers and other areas of high unmet need.
We strive to put patient priorities first in our research, advancing our understanding of sleep conditions and the needs of those with narcolepsy and idiopathic hypersomnia.
People with sleep conditions, such as narcolepsy and idiopathic hypersomnia, have an increased prevalence of cardiovascular comorbidities compared to people without these sleep conditions. At Jazz, we aim to raise awareness of these connections through our research and partnerships with the goal of providing patients and healthcare providers with meaningful insights that can impact their lives.